The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...

Lisa Jarvis In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

As the year draws to a close, Wall Street is set to crown Eli Lilly (NYSE:LLY) among the best in Big Pharma, while Novo ...

President-elect Donald Trump has asked the Supreme Court to delay implementation of the law banning TikTok. Western officials say North Korean soldiers are dying in high numbers along the Ukrainian ...

NBA Hall of Famer Isiah Thomas announced Thursday that he has been diagnosed with Bell’s palsy. “I’ve gotten a lot of love ...